Clinical trials: Watch & Wait
HCC - Hepatocellular Carcinoma, Watch & Wait
Surgery vs. Watch-and-Wait Strategy in Partial & Complete Responders for Hepatocellular Carcinoma
The "Surgery versus Maintenance after Conversion-therapy-achieved Complete/Partial Response in Hepatocellular Carcinoma (SWITCH)" study is a multicenter, open-label, prospective non-randomized cohort study with the protocol…
- Conditions
- HCC - Hepatocellular Carcinoma, Watch & Wait, Surgery
- Trial name
- SWITCH (NCT07410715)
- Testing
- Surgical Resection, Maintenance Therapy Group
- Where
- China
- Volunteers
- 100 people
- Sponsor
- West China Hospital
Randomized, Phase 2
Randomized Phase 2 Study Of Epcoritamab Vs Watch And Wait InPatients With Previously Untreated Low Tumor Burden FollicularLymphoma
To compare the time to next treatment between patients with previously untreated, low tumor burden FL who receive the study drug epcoritamab versus those who do not receive epcoritamab and are monitored only.
- Conditions
- Randomized, Phase 2, Epcoritamab, Watch & Wait
- Trial name
- NCT07783594
- Testing
- Epcoritamab, Observation
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- M.D. Anderson Cancer Center
Rectal Cancer, Chemoradiotherapy
Non-OpeRative MANagement of Rectal Cancer Patients
This study is a single-center, open, prospective, single-treatment trial (pilot study). This study aims to analyze the treatment results after receiving capecitabine adjuvant chemotherapy for 4 months after non-surgical treatment…
- Conditions
- Rectal Cancer, Chemoradiotherapy, Watch & Wait
- Trial name
- NORMANDY (NCT04696757)
- Testing
- Capecitabine
- Where
- South Korea
- Volunteers
- 18 people
- Sponsor
- Kangbuk Samsung Hospital